Eliav Barr

1991–2022 年に発表

53
論文数
19,033
被引用数
51
h 指数
53
i10 指数

被引用数

Eliav Barr の年別被引用数1992 年: 被引用 5 件1993 年: 被引用 20 件1994 年: 被引用 16 件1995 年: 被引用 16 件1996 年: 被引用 32 件1997 年: 被引用 40 件1998 年: 被引用 23 件1999 年: 被引用 21 件2000 年: 被引用 19 件2001 年: 被引用 17 件2002 年: 被引用 30 件2003 年: 被引用 64 件2004 年: 被引用 100 件2005 年: 被引用 127 件2006 年: 被引用 212 件2007 年: 被引用 261 件2008 年: 被引用 191 件2009 年: 被引用 220 件2010 年: 被引用 205 件2011 年: 被引用 194 件2012 年: 被引用 182 件2013 年: 被引用 152 件2014 年: 被引用 125 件2015 年: 被引用 181 件2016 年: 被引用 171 件2017 年: 被引用 139 件2018 年: 被引用 135 件2019 年: 被引用 363 件2020 年: 被引用 276 件2021 年: 被引用 228 件2022 年: 被引用 150 件2023 年: 被引用 117 件2024 年: 被引用 143 件2025 年: 被引用 87 件2026 年: 被引用 1 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,511 件、この内訳の 31.3%イギリス: 引用元論文 323 件、この内訳の 6.7%カナダ: 引用元論文 247 件、この内訳の 5.1%オーストラリア: 引用元論文 215 件、この内訳の 4.4%フランス: 引用元論文 192 件、この内訳の 4%ドイツ: 引用元論文 177 件、この内訳の 3.7%イタリア: 引用元論文 152 件、この内訳の 3.1%ベルギー: 引用元論文 133 件、この内訳の 2.7%スペイン: 引用元論文 132 件、この内訳の 2.7%中国: 引用元論文 129 件、この内訳の 2.7%オランダ: 引用元論文 115 件、この内訳の 2.4%スウェーデン: 引用元論文 87 件、この内訳の 1.8%
0%31.3%その他 29.4%

分野

  • Medicine81.6%
  • Biochemistry, Genetics and Molecular Biology8.2%
  • Immunology and Microbiology4.4%
  • Social Sciences1.8%
  • Environmental Science0.6%
  • Health Professions0.5%
  • その他2.9%

トピック

  • Cervical Cancer and HPV Research16.5%
  • Hepatitis B Virus Studies7.2%
  • Hepatitis C virus research4.3%
  • Genital Health and Disease4.3%
  • Head and Neck Cancer Studies3.8%
  • Vaccine Coverage and Hesitancy3.8%
  • その他60.1%

共著者

全論文

検索で開く
  1. Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males

    著者: , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2011 被引用: 1,141

  2. Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases

    著者: , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2007 被引用: 1,899

  3. ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES

    著者: , , , , , , , , , - 2006 被引用: 940

  4. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2005 被引用: 1,580

  5. Natural History of Genital Warts: Analysis of the Placebo Arm of 2 Randomized Phase III Trials of a Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Vaccine

    著者: , , , , , , , , - The Journal of Infectious Diseases 2009 被引用: 531

  6. Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials

    著者: , , , , , , , , , , , , , , , , , , , , , - The Lancet 2007 被引用: 580

  7. Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24–45 years: a randomised, double-blind trial

    著者: , , , , , , , , , , , , , , , , , - The Lancet 2009 被引用: 480

  8. Reinfection and Risk Behaviors After Treatment of Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy

    著者: , , , , , , , , , , , , , , , , , , , , - Annals of Internal Medicine 2022 被引用: 19

  9. A Controlled Trial of a Human Papillomavirus Type 16 Vaccine

    著者: , , , , , , , - New England Journal of Medicine 2002 被引用: 1,608

  10. The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV‐Naive Women Aged 16–26 Years

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lisa Lupinacci, Katherine Giacoletti, Heather L. Sings, Margaret K. James, Teresa M. Hesley, Eliav Barr - The Journal of Infectious Diseases 2009 被引用: 627

  11. Elbasvir–Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy

    著者: , , , , , , , , , , , , , , , , , , , , , , - Annals of Internal Medicine 2016 被引用: 363

  12. Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Janine T. Bryan, Lisa Lupinacci, Katherine Giacoletti, Heather L. Sings, Margaret K. James, Teresa M. Hesley, Eliav Barr, Richard M. Haupt - JNCI Journal of the National Cancer Institute 2010 被引用: 564

  13. Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eliav Barr - Vaccine 2006 被引用: 469

  14. A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine against High-grade Cervical and External Genital Lesions

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Roger Maansson, Shuang Lu, Scott Vuocolo, Teresa M. Hesley, Alfred J. Saah, Eliav Barr, Richard M. Haupt - Cancer Prevention Research 2009 被引用: 328

  15. The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Sexually Active Women Aged 16–26 Years

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lisa Lupinacci, Katherine Giacoletti, Margaret K. James, Scott Vuocolo, Teresa M. Hesley, Eliav Barr - The Journal of Infectious Diseases 2009 被引用: 242

  16. Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine

    著者: , , , , , , , , , , , , , , , , , , , , , - Vaccine 2007 被引用: 456

  17. Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4–5 chronic kidney disease (the C-SURFER study): a combination phase 3 study

    著者: , , , , , , , , , , , , , , , , , , - The Lancet 2015 被引用: 666

  18. HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Janine T. Bryan, Lisa Lupinacci, Katherine Giacoletti, Shuang Lu, Scott Vuocolo, Teresa M. Hesley, Richard M. Haupt, Eliav Barr - Vaccine 2008 被引用: 196

  19. Grazoprevir–Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection

    著者: , , , , , , , , , , , , , - Annals of Internal Medicine 2015 被引用: 517

  20. Comparison of the Immunogenicity and Reactogenicity of a Prophylactic Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine in Male and Female Adolescents and Young Adult Women

    著者: , , , , , , , , , , , , - PEDIATRICS 2006 被引用: 485

  21. Efficacy of Human Papillomavirus-16 Vaccine to Prevent Cervical Intraepithelial Neoplasia

    著者: , , , , , , , , , - Obstetrics and Gynecology 2006 被引用: 453

  22. Antibodies from Women Immunized with Gardasil ® Cross-Neutralize HPV 45 Pseudovirions

    著者: , , , , , , , , - Human Vaccines 2007 被引用: 136

  23. Impact of Baseline Covariates on the Immunogenicity of a Quadrivalent (Types 6, 11, 16, and 18) Human Papillomavirus Virus‐Like‐Particle Vaccine

    著者: , , , , , , , , , , , - The Journal of Infectious Diseases 2007 被引用: 120

  24. Longitudinal Evaluation of Interobserver and Intraobserver Agreement of Cervical Intraepithelial Neoplasia Diagnosis Among an Experienced Panel of Gynecologic Pathologists

    著者: , , , , , , , , , , - The American Journal of Surgical Pathology 2007 被引用: 58